Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

19
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Annals of neurology·2026
Same author

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Epidemiology of multiple sclerosis in a healthcare area of the Basque Country, Northern Spain: A population-based study (2009-2023).

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

Redefining Multiple Sclerosis: Toward a Biologically Driven Diagnosis.

Neurology·2026
Same author

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Brain : a journal of neurology·2026

Related Experiment Video

Updated: Apr 28, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

Biomarkers in multiple sclerosis: an update for 2014.

Oscar Fernandez1, Roland Martin, Alex Rovira

  • 1Fundacion IMABIS, Hospital Universitario Carlos Haya, 29190 Malaga, Espana.

Revista De Neurologia
|June 11, 2014
PubMed
Summary

This review explores biomarkers for multiple sclerosis (MS), a chronic central nervous system disease. Understanding these markers is key to improving patient prognosis and treatment effectiveness.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K

Related Experiment Videos

Last Updated: Apr 28, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Background:

  • Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system affecting young adults.
  • MS pathology involves inflammation, demyelination, and axonal damage, leading to varied disease progression and treatment responses.
  • Accurate prognosis and treatment efficacy determination are challenging due to disease heterogeneity.

Purpose of the Study:

  • To provide an updated overview of validated biomarkers currently used in multiple sclerosis (MS) clinical practice.
  • To identify and discuss potential novel biomarkers for future routine use in MS management.
  • To emphasize the need for advanced biomarker research, particularly for later disease stages, to halt disability progression.

Main Methods:

  • This review synthesizes current scientific literature and clinical research findings.
  • It focuses on validated and candidate biomarkers relevant to multiple sclerosis (MS).
  • Information is gathered on biomarkers for both early and advanced stages of the disease.

Main Results:

  • Significant advancements have been made in identifying biomarkers, especially for early-stage MS.
  • Several validated biomarkers are currently in use, aiding in disease management.
  • Numerous candidate biomarkers show promise for future clinical application.

Conclusions:

  • Further research into novel biomarkers is crucial for all stages of multiple sclerosis (MS).
  • Identifying new markers can help halt disability progression and inform new therapeutic strategies.
  • Integrating advanced biomarkers into routine practice will enhance personalized MS care and treatment outcomes.